SG11202100996TA - PROMOTER of Hspa8 GENE - Google Patents

PROMOTER of Hspa8 GENE

Info

Publication number
SG11202100996TA
SG11202100996TA SG11202100996TA SG11202100996TA SG11202100996TA SG 11202100996T A SG11202100996T A SG 11202100996TA SG 11202100996T A SG11202100996T A SG 11202100996TA SG 11202100996T A SG11202100996T A SG 11202100996TA SG 11202100996T A SG11202100996T A SG 11202100996TA
Authority
SG
Singapore
Prior art keywords
promoter
hspa8 gene
hspa8
gene
Prior art date
Application number
SG11202100996TA
Other languages
English (en)
Inventor
Kenji Masuda
Yuto Nakazawa
Kazuhiko Watanabe
Maui Nishio
Takeshi Okumura
Koichi Nonaka
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of SG11202100996TA publication Critical patent/SG11202100996TA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
SG11202100996TA 2018-08-09 2019-08-08 PROMOTER of Hspa8 GENE SG11202100996TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018149854 2018-08-09
PCT/JP2019/031295 WO2020032153A1 (ja) 2018-08-09 2019-08-08 Ｈｓｐａ８遺伝子のプロモーター

Publications (1)

Publication Number Publication Date
SG11202100996TA true SG11202100996TA (en) 2021-03-30

Family

ID=69415548

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202100996TA SG11202100996TA (en) 2018-08-09 2019-08-08 PROMOTER of Hspa8 GENE

Country Status (10)

Country Link
US (1) US20210317498A1 (ja)
EP (1) EP3835423A4 (ja)
JP (1) JPWO2020032153A1 (ja)
KR (1) KR20210042084A (ja)
CN (1) CN112639098A (ja)
AU (1) AU2019318910A1 (ja)
CA (1) CA3109101A1 (ja)
SG (1) SG11202100996TA (ja)
TW (1) TW202020160A (ja)
WO (1) WO2020032153A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202146432A (zh) * 2020-04-03 2021-12-16 日商第一三共股份有限公司 新基因表現單元
TW202400789A (zh) * 2022-04-26 2024-01-01 日商第一三共股份有限公司 Ｅｎｏ１基因的啟動子

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3051411U (ja) 1997-04-25 1998-08-25 信一 朝長 安全プラグ
US7056897B2 (en) * 1997-11-03 2006-06-06 The Arizona Board Of Regents Inducible expression vectors and methods of use thereof
GB0509965D0 (en) 2005-05-17 2005-06-22 Ml Lab Plc Improved expression elements
EP3093351B1 (en) * 2008-07-09 2018-04-18 Celera Corporation Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
JP6336755B2 (ja) * 2010-11-12 2018-06-06 ザ ジェネラル ホスピタル コーポレイション ポリコームに関連する非コードｒｎａ
TW201632624A (zh) * 2011-11-28 2016-09-16 第一三共股份有限公司 源自人類基因的啟動子
PT3456339T (pt) * 2013-08-05 2021-12-09 Immatics Biotechnologies Gmbh Nova imunoterapia contra vários tumores, tais como cancro do pulmão, incluindo cpnpc
CN105018528B (zh) * 2015-08-20 2018-04-03 重庆大学 热休克蛋白基因启动子和四环素基因启动子控制的多基因表达和沉默系统
JP7382138B2 (ja) 2016-10-03 2023-11-16 第一三共株式会社 Ｈｓｐａ５遺伝子のプロモーター

Also Published As

Publication number Publication date
CA3109101A1 (en) 2020-02-13
EP3835423A1 (en) 2021-06-16
EP3835423A4 (en) 2022-08-10
TW202020160A (zh) 2020-06-01
KR20210042084A (ko) 2021-04-16
US20210317498A1 (en) 2021-10-14
WO2020032153A1 (ja) 2020-02-13
CN112639098A (zh) 2021-04-09
AU2019318910A1 (en) 2021-02-18
JPWO2020032153A1 (ja) 2021-08-12

Similar Documents

Publication Publication Date Title
IL280391A (en) expendable
IL286218A (en) Solid state forms of ripretinib
GB2598055B (en) Suspension assembly
GB201904612D0 (en) Reaction of glycoladehyde
GB2605906B (en) Actively controlled bailer
SG11202100996TA (en) PROMOTER of Hspa8 GENE
GB201810253D0 (en) Gene drive
SG10201912370RA (en) PROMOTER OF Hspa5 GENE
GB201814990D0 (en) Consumable
GB201805865D0 (en) Genes
ZA202105399B (en) Use of spiropidion
GB201911522D0 (en) Genetic construct
GB201814986D0 (en) Consumable
GB201903499D0 (en) Minimal promoter
GB201915706D0 (en) Stabiliser
GB2581335B (en) Docking arrangement
GB201915082D0 (en) Suspension
GB201908958D0 (en) Rt
GB201905220D0 (en) Forskolin-inducible promoters
GB201905219D0 (en) Hypoxia-enducible promoters
GB201917045D0 (en) Genetic construct
GB201912932D0 (en) Suspension assembly
GB201901165D0 (en) Genetic construct
GB201803398D0 (en) Methods for controlling gene expression
GB201814995D0 (en) Consumable